NCT06038890

Brief Summary

Despite the high-quality evidence supporting the safety and efficacy of Holmium laser enucleation of the prostate (HOLEP), wide adoption of the procedure is hindered by learning difficulties. Veil-sparing HOLEP was popularized with a standardized approach to learning. Prospective multicenter assessment of the learning curve of HoLEP through a novel technique with structured learning protocol. Learning outcome measures will be assessed against time and number of performed cases of new learners in a multicenter study.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 10, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 15, 2023

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

September 15, 2023

Status Verified

September 1, 2023

Enrollment Period

2 years

First QC Date

September 10, 2023

Last Update Submit

September 10, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • time to plateau in enucleation effeminacy

    time needed to reach a fixed rate of grams of prostate tissue removed per unit time (minute)

    one year

Study Arms (1)

Holmium laser enculeation of the prostate

EXPERIMENTAL

veil-sparing Holmium laser enucleation of the prostate

Procedure: Holmium laser enucleation of the prostate using the veil-sparing technique

Interventions

Holmium laser enucleation of the prostate using the veil-sparing technique

Holmium laser enculeation of the prostate

Eligibility Criteria

Age40 Years+
Sexmale(Gender-based eligibility)
Gender Eligibility Detailsprostate surgery offered only for men
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with prostate volume (≥40 cc) who are indicated for transurethral surgery for the BPO.

You may not qualify if:

  • Patients with IPSS \<13.
  • Patients with Qmax \>15 mL/s.
  • Presence of urethral stricture.
  • Patients with neurogenic bladder.
  • Patients with prostate cancer.
  • Patients with previous prostate surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Urology and nephrology center

Al Mansurah, DK, 35516, Egypt

RECRUITING

MeSH Terms

Conditions

Prostatic Hyperplasia

Condition Hierarchy (Ancestors)

Prostatic DiseasesGenital Diseases, MaleGenital DiseasesUrogenital DiseasesMale Urogenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: A single cohort of consecutively performed cases in participating centers done by new learners using the assigned technique
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Urology

Study Record Dates

First Submitted

September 10, 2023

First Posted

September 15, 2023

Study Start

August 1, 2023

Primary Completion

August 1, 2025

Study Completion

December 1, 2025

Last Updated

September 15, 2023

Record last verified: 2023-09

Locations